381 related articles for article (PubMed ID: 19188658)
1. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.
Kulasekaran P; Scavone CA; Rogers DS; Arenberg DA; Thannickal VJ; Horowitz JC
Am J Respir Cell Mol Biol; 2009 Oct; 41(4):484-93. PubMed ID: 19188658
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.
Horowitz JC; Rogers DS; Sharma V; Vittal R; White ES; Cui Z; Thannickal VJ
Cell Signal; 2007 Apr; 19(4):761-71. PubMed ID: 17113264
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.
Martin MM; Buckenberger JA; Jiang J; Malana GE; Knoell DL; Feldman DS; Elton TS
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L790-9. PubMed ID: 17601799
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
[TBL] [Abstract][Full Text] [Related]
5. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
Voloshenyuk TG; Landesman ES; Khoutorova E; Hart AD; Gardner JD
Cytokine; 2011 Jul; 55(1):90-7. PubMed ID: 21498085
[TBL] [Abstract][Full Text] [Related]
6. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
Horowitz JC; Lee DY; Waghray M; Keshamouni VG; Thomas PE; Zhang H; Cui Z; Thannickal VJ
J Biol Chem; 2004 Jan; 279(2):1359-67. PubMed ID: 14576166
[TBL] [Abstract][Full Text] [Related]
7. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
8. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase.
Tong XK; Hamel E
Mol Pharmacol; 2007 Dec; 72(6):1476-83. PubMed ID: 17848599
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.
Lin CC; Chiang LL; Lin CH; Shih CH; Liao YT; Hsu MJ; Chen BC
Eur J Pharmacol; 2007 Apr; 560(2-3):101-9. PubMed ID: 17307160
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits TGF-β1-induced fibrotic effects in human pterygium fibroblasts.
Fan J; Wei S; Zhang X; Chen L; Zhang X; Jiang Y; Sheng M; Chen Y
Environ Health Prev Med; 2023; 28():59. PubMed ID: 37866886
[TBL] [Abstract][Full Text] [Related]
14. Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways.
Nie Y; Yang Y; Zhang J; Cai G; Chang Y; Chai G; Guo C
Biomed Pharmacother; 2017 Nov; 95():1119-1128. PubMed ID: 28922731
[TBL] [Abstract][Full Text] [Related]
15. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
16. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts.
Hou TY; Wu SB; Kau HC; Tsai CC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.
Rodríguez-Barbero A; Dorado F; Velasco S; Pandiella A; Banas B; López-Novoa JM
Kidney Int; 2006 Sep; 70(5):901-9. PubMed ID: 16820791
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
[TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
[TBL] [Abstract][Full Text] [Related]
20. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
